| Literature DB >> 32276959 |
Thomas M Lilley1,2, Ian W Wilson3, Kenneth A Field4, DeeAnn M Reeder4, Megan E Vodzak4, Gregory G Turner5, Allen Kurta6, Anna S Blomberg7, Samantha Hoff8, Carl J Herzog8, Brent J Sewall9, Steve Paterson3.
Abstract
Novel pathogens can cause massive declines in populations, and even extirpation of hosts. But disease can also act as a selective pressure on survivors, driving the evolution of resistance or tolerance. Bat white-nose syndrome (WNS) is a rapidly spreading wildlife disease in North America. The fungus causing the disease invades skin tissues of hibernating bats, resulting in disruption of hibernation behavior, premature energy depletion, and subsequent death. We used whole-genome sequencing to investigate changes in allele frequencies within a population of Myotis lucifugus in eastern North America to search for genetic resistance to WNS. Our results show low FST values within the population across time, i.e., prior to WNS (Pre-WNS) compared to the population that has survived WNS (Post-WNS). However, when dividing the population with a geographical cut-off between the states of Pennsylvania and New York, a sharp increase in values on scaffold GL429776 is evident in the Post-WNS samples. Genes present in the diverged area are associated with thermoregulation and promotion of brown fat production. Thus, although WNS may not have subjected the entire M. lucifugus population to selective pressure, it may have selected for specific alleles in Pennsylvania through decreased gene flow within the population. However, the persistence of remnant sub-populations in the aftermath of WNS is likely due to multiple factors in bat life history.Entities:
Keywords: Genetic resistance; Opportunistic pathogen; Selective pressure; white-nose syndrome
Mesh:
Year: 2020 PMID: 32276959 PMCID: PMC7263666 DOI: 10.1534/g3.119.400966
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
- Samples used in study. WNS first detected in New York in 2006 and PA in 2009
| Sample age | Classification | Total number of samples | Pennsylvania | New York |
|---|---|---|---|---|
| 2006 | Pre-WNS | 25 | 25 | |
| 2007 | Pre-WNS | 27 | 4 | 24 |
| 2015 | Post-WNS | 28 | 28 | |
| 2016 | Post-WNS | 139 | 82 | 57 |
Figure 1Myotis lucifugus sampling sites in Pennsylvania (PA) and New York (NY). Pre-WNS-sites in gray circles and Post-WNS-sites in white circles. Point 5 is Hailes Cave, near the first point of discovery of WNS. Site numbers correspond to Supplemental Table 1. Sample numbers per site 1) n = 3; 2) n = 19; 3) n = 3; 4) n = 2; 5) n = 24; 6) n = 32; 7) n = 14; 8) n = 20; 9) n = 4; 10) n = 12; 11) n = 12; 12) n = 16; 13) n = 8; 14) n = 36; and 15) n = 21.
- Summary of individual SNP FST values across the M. lucifugus genome when comparing Pre-WNS with Post-WNS; and samples from PA and NY (both Pre- and Post-WNS)
| Pre- | Between site (combining pre- and post-WNS) | |
|---|---|---|
| 0.0059 (0.0013 – 0.0171) | 0.0057 (0.0013 – 0.0165) | |
| 0.0127 (0.0173) | 0.0123 (0.0170) |
Figure 2Fixation indices (FST) across the M. lucifugus genome, comparing the population before and after the arrival of white-nose syndrome. Scaffold lengths presented in green and blue. Solid red line indicates cut-off for FST values of 5 standard deviations from the mean across the whole genome.
Figure 3Fixation indices (FST) across the M. lucifugus genome between geographically separated individuals of the study population: A) comparing individuals from PA to individuals from NY before the arrival of WNS; B) comparing individuals from PA before and after the arrival of WNS; and C) comparing individuals from NY before and after the arrival of WNS. Scaffold lengths presented in green and blue. Solid red line indicates cut-off for FST values of 5 standard deviations from the mean across the whole genome; dotted red line indicates cut-off of FST = 0.05. Windows exceeding this cutoff of FST = 0.05 are colored red.
Figure 4Fixation indices (FST) across the M. lucifugus genome between geographically separated individuals of the study population: A) comparing individuals from PA to individuals from NY after the arrival of WNS, with a zoomed plot of scaffold GL429776 and gene models therein containing windows demonstrating FST values > 0.05; and B) comparing individuals from PA to individuals from NY with Pre- and Post-WNS data combined. Scaffold lengths presented in green and blue. Solid red line indicates cut-off for FST values of 5 standard deviations from the mean across the whole genome; dotted red line indicates cut-off of FST = 0.05. Windows exceeding this cutoff of FST = 0.05 are colored red.
- Genes within the M. lucifugus genome – excluding scaffold GL429776 – with windows possessing FST values >= 0.05 when comparing PA and NY samples Post-WNS
| Scaffold | Location range (bp) | Gene ID | Protein Function | Number of overlapping high FST windows |
|---|---|---|---|---|
| NW_005871715.1 | 288334 - 351644 | 102435296 | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4-like (partial) | 4 |
| NW_005871771.1 | 26662 - 48938 | 102441697 | E3 ubiquitin-protein ligase TRIM7 | 1 |
| NW_005871823.1 | 81353 - 213965 | 102428352 | Ankyrin 2 | 7 |
| NW_005871905.1 | 175 - 139344 | 102428043 | calcium/calmodulin-dependent protein kinase type II subunit delta-like | 10 |
| NW_005872026.1 | 72042 - 101269 | 102443179 | N-deacetylase and N-sulfotransferase 4 (partial) | 1 |
| NW_005872062.1 | 33266 - 86607 | 102428048 | zinc finger GRF-type containing 1 | 1 |
Figure 5Proportions of reference alleles called at individual SNP sites for the region of scaffold GL429776 demonstrating high FST values when comparing: A) individuals from Pennsylvania before and after the arrival of WNS; B) individuals from NY before and after the arrival of WNS; C) individuals from PA to individuals from NY before the arrival of WNS; and D) individuals from PA to individuals from NY after the arrival of WNS.
- Genes within scaffold GL429776 with windows possessing FST values >= 0.05 when comparing PA and NY samples Post-WNS
| Gene ID | FST | No of windows | No of windows (per 10kb) | Start pos. | End pos. | Details |
|---|---|---|---|---|---|---|
| 0.0612 | 78 | 1.08 | 8999210 | 9724150 | Glycosyltransferase that participates in the transfer of N-acetylglucosamine (GlcNAc) to the core mannose residues of N-linked glycans | |
| 0.0679 | 12 | 1.01 | 10709418 | 10827912 | Involved in early and late steps in cilia formation | |
| 0.0826 | 12 | 0.89 | 12228178 | 12362389 | The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. | |
| 0.0706 | 10 | 1.13 | 11127130 | 11215731 | Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. | |
| 0.0686 | 7 | 0.74 | 12044678 | 12139811 | Plays an important role in centriole assembly and/or stability and ciliogenesis | |
| 0.0872 | 6 | 1.00 | 10827719 | 10887502 | Involved in the positive regulation of proteasomal protein degradation in the endoplasmic reticulum (ER), and the control of ER stress response. | |
| GeneID:111824954 | 0.0693 | 5 | 1.14 | 11756928 | 11800690 | uncharacterized LOC111824954 |
| 0.0588 | 2 | 0.67 | 10663328 | 10693373 | chromosome unknown C12orf50 homolog | |
| GeneID:111824948 | 0.0816 | 2 | 1.13 | 11375011 | 11392720 | uncharacterized LOC111824948 |
| GeneID:111824949 | 0.0635 | 2 | 1.14 | 11802704 | 11820273 | uncharacterized LOC111824949 |
| 0.0488 | 1 | 0.71 | 10696290 | 10710421 | chromosome unknown C12orf29 homolog | |
| 0.0603 | 1 | 2.26 | 11976039 | 11980455 | Inactivates MAP kinases. | |
| GeneID:111824955 | 0.0459 | 1 | 1.57 | 12101754 | 12108133 | uncharacterized LOC111824955 |